International Pharmaceutical Regulatory Monitor

July 2012 | Vol. 40 No. 7

Pharma Stakeholders Call for Single Global Marketing Application

The U.S. Food and Drug Administration (FDA) should work with other regulatory bodies, especially the European Medicines Agency (EMA), to create a single marketing application that would be accepted by multiple regulators, U.S. drug industry insiders urge.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

FDA, UK May Need to Inspect More Under New EU Generic API Import Rules Mallinckrodt’s Generic Concerta Exclusivity May Hinge on Outcome of Generic Actos Exclusivity Battle: Expert FDA Maintains Lead in Cancer Drug Approvals, New Study Finds Format Tweaks Needed Between FDA, EMA eCTD Submissions

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.